Global and United States Cell Viability Assays Market Report & Forecast 2024-2031

Report ID: 1861794 | Published Date: Oct 2024 | No. of Page: 100 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cell Viability Assays Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cell Viability Assays Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cell Viability Assays Market Size for the Year 2017-2028
        1.2.2 Global Cell Viability Assays Market Size for the Year 2017-2028
    1.3 Cell Viability Assays Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cell Viability Assays in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cell Viability Assays Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cell Viability Assays Market Dynamics
        1.4.1 Cell Viability Assays Industry Trends
        1.4.2 Cell Viability Assays Market Drivers
        1.4.3 Cell Viability Assays Market Challenges
        1.4.4 Cell Viability Assays Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cell Viability Assays by Type
    2.1 Cell Viability Assays Market Segment by Type
        2.1.1 Human Cells
        2.1.2 Microbial Cells
        2.1.3 Animal Cells
    2.2 Global Cell Viability Assays Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cell Viability Assays Market Size by Type (2017-2028)
    2.4 United States Cell Viability Assays Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cell Viability Assays Market Size by Type (2017-2028)
3 Cell Viability Assays by Application
    3.1 Cell Viability Assays Market Segment by Application
        3.1.1 Pharmaceutical and Biotechnology Companies
        3.1.2 Academic and Research Institutes
        3.1.3 Hospital and Diagnostic Laboratories
        3.1.4 Others
    3.2 Global Cell Viability Assays Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cell Viability Assays Market Size by Application (2017-2028)
    3.4 United States Cell Viability Assays Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cell Viability Assays Market Size by Application (2017-2028)
4 Global Cell Viability Assays Competitor Landscape by Company
    4.1 Global Cell Viability Assays Market Size by Company
        4.1.1 Top Global Cell Viability Assays Companies Ranked by Revenue (2021)
        4.1.2 Global Cell Viability Assays Revenue by Player (2017-2022)
    4.2 Global Cell Viability Assays Concentration Ratio (CR)
        4.2.1 Cell Viability Assays Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cell Viability Assays in 2021
        4.2.3 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cell Viability Assays Headquarters, Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cell Viability Assays Headquarters and Area Served
        4.3.2 Global Cell Viability Assays Companies Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cell Viability Assays Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cell Viability Assays Market Size by Company
        4.5.1 Top Cell Viability Assays Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cell Viability Assays Revenue by Players (2020, 2021 & 2022)
5 Global Cell Viability Assays Market Size by Region
    5.1 Global Cell Viability Assays Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cell Viability Assays Market Size by Region (2017-2028)
        5.2.1 Global Cell Viability Assays Market Size by Region: 2017-2022
        5.2.2 Global Cell Viability Assays Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cell Viability Assays Market Size YoY Growth 2017-2028
        6.1.2 North America Cell Viability Assays Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cell Viability Assays Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cell Viability Assays Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cell Viability Assays Market Size YoY Growth 2017-2028
        6.3.2 Europe Cell Viability Assays Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cell Viability Assays Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cell Viability Assays Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cell Viability Assays Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cell Viability Assays Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Thermo Fisher Scientific
        7.1.1 Thermo Fisher Scientific Company Details
        7.1.2 Thermo Fisher Scientific Business Overview
        7.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction
        7.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022)
        7.1.5 Thermo Fisher Scientific Recent Development
    7.2 Merck
        7.2.1 Merck Company Details
        7.2.2 Merck Business Overview
        7.2.3 Merck Cell Viability Assays Introduction
        7.2.4 Merck Revenue in Cell Viability Assays Business (2017-2022)
        7.2.5 Merck Recent Development
    7.3 Bio-Rad
        7.3.1 Bio-Rad Company Details
        7.3.2 Bio-Rad Business Overview
        7.3.3 Bio-Rad Cell Viability Assays Introduction
        7.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2017-2022)
        7.3.5 Bio-Rad Recent Development
    7.4 GE
        7.4.1 GE Company Details
        7.4.2 GE Business Overview
        7.4.3 GE Cell Viability Assays Introduction
        7.4.4 GE Revenue in Cell Viability Assays Business (2017-2022)
        7.4.5 GE Recent Development
    7.5 Danaher
        7.5.1 Danaher Company Details
        7.5.2 Danaher Business Overview
        7.5.3 Danaher Cell Viability Assays Introduction
        7.5.4 Danaher Revenue in Cell Viability Assays Business (2017-2022)
        7.5.5 Danaher Recent Development
    7.6 BD
        7.6.1 BD Company Details
        7.6.2 BD Business Overview
        7.6.3 BD Cell Viability Assays Introduction
        7.6.4 BD Revenue in Cell Viability Assays Business (2017-2022)
        7.6.5 BD Recent Development
    7.7 PerkinElmer
        7.7.1 PerkinElmer Company Details
        7.7.2 PerkinElmer Business Overview
        7.7.3 PerkinElmer Cell Viability Assays Introduction
        7.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2017-2022)
        7.7.5 PerkinElmer Recent Development
    7.8 Promega
        7.8.1 Promega Company Details
        7.8.2 Promega Business Overview
        7.8.3 Promega Cell Viability Assays Introduction
        7.8.4 Promega Revenue in Cell Viability Assays Business (2017-2022)
        7.8.5 Promega Recent Development
    7.9 Biotium
        7.9.1 Biotium Company Details
        7.9.2 Biotium Business Overview
        7.9.3 Biotium Cell Viability Assays Introduction
        7.9.4 Biotium Revenue in Cell Viability Assays Business (2017-2022)
        7.9.5 Biotium Recent Development
    7.10 Abcam
        7.10.1 Abcam Company Details
        7.10.2 Abcam Business Overview
        7.10.3 Abcam Cell Viability Assays Introduction
        7.10.4 Abcam Revenue in Cell Viability Assays Business (2017-2022)
        7.10.5 Abcam Recent Development
    7.11 Creative Bioarray
        7.11.1 Creative Bioarray Company Details
        7.11.2 Creative Bioarray Business Overview
        7.11.3 Creative Bioarray Cell Viability Assays Introduction
        7.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022)
        7.11.5 Creative Bioarray Recent Development
    7.12 Biotek Instruments
        7.12.1 Biotek Instruments Company Details
        7.12.2 Biotek Instruments Business Overview
        7.12.3 Biotek Instruments Cell Viability Assays Introduction
        7.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022)
        7.12.5 Biotek Instruments Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cell Viability Assays Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cell Viability Assays Market Trends
    Table 3. Cell Viability Assays Market Drivers
    Table 4. Cell Viability Assays Market Challenges
    Table 5. Cell Viability Assays Market Restraints
    Table 6. Global Cell Viability Assays Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cell Viability Assays Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cell Viability Assays Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cell Viability Assays Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cell Viability Assays Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cell Viability Assays Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cell Viability Assays Revenue Share by Player, 2017-2022
    Table 13. Global Cell Viability Assays Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cell Viability Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
    Table 15. Top Players of Cell Viability Assays in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cell Viability Assays Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cell Viability Assays Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cell Viability Assays Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cell Viability Assays Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cell Viability Assays Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cell Viability Assays Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cell Viability Assays Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cell Viability Assays Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cell Viability Assays Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cell Viability Assays Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cell Viability Assays Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Thermo Fisher Scientific Company Details
    Table 31. Thermo Fisher Scientific Business Overview
    Table 32. Thermo Fisher Scientific Cell Viability Assays Product
    Table 33. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 34. Thermo Fisher Scientific Recent Development
    Table 35. Merck Company Details
    Table 36. Merck Business Overview
    Table 37. Merck Cell Viability Assays Product
    Table 38. Merck Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 39. Merck Recent Development
    Table 40. Bio-Rad Company Details
    Table 41. Bio-Rad Business Overview
    Table 42. Bio-Rad Cell Viability Assays Product
    Table 43. Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 44. Bio-Rad Recent Development
    Table 45. GE Company Details
    Table 46. GE Business Overview
    Table 47. GE Cell Viability Assays Product
    Table 48. GE Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 49. GE Recent Development
    Table 50. Danaher Company Details
    Table 51. Danaher Business Overview
    Table 52. Danaher Cell Viability Assays Product
    Table 53. Danaher Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 54. Danaher Recent Development
    Table 55. BD Company Details
    Table 56. BD Business Overview
    Table 57. BD Cell Viability Assays Product
    Table 58. BD Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 59. BD Recent Development
    Table 60. PerkinElmer Company Details
    Table 61. PerkinElmer Business Overview
    Table 62. PerkinElmer Cell Viability Assays Product
    Table 63. PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 64. PerkinElmer Recent Development
    Table 65. Promega Company Details
    Table 66. Promega Business Overview
    Table 67. Promega Cell Viability Assays Product
    Table 68. Promega Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 69. Promega Recent Development
    Table 70. Biotium Company Details
    Table 71. Biotium Business Overview
    Table 72. Biotium Cell Viability Assays Product
    Table 73. Biotium Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 74. Biotium Recent Development
    Table 75. Abcam Company Details
    Table 76. Abcam Business Overview
    Table 77. Abcam Cell Viability Assays Product
    Table 78. Abcam Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 79. Abcam Recent Development
    Table 80. Creative Bioarray Company Details
    Table 81. Creative Bioarray Business Overview
    Table 82. Creative Bioarray Cell Viability Assays Product
    Table 83. Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 84. Creative Bioarray Recent Development
    Table 85. Biotek Instruments Company Details
    Table 86. Biotek Instruments Business Overview
    Table 87. Biotek Instruments Cell Viability Assays Product
    Table 88. Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
    Table 89. Biotek Instruments Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cell Viability Assays Product Picture
    Figure 2. Global Cell Viability Assays Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cell Viability Assays Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cell Viability Assays Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cell Viability Assays Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cell Viability Assays Market Share in Global 2017-2028
    Figure 7. Cell Viability Assays Report Years Considered
    Figure 8. Product Picture of Human Cells
    Figure 9. Product Picture of Microbial Cells
    Figure 10. Product Picture of Animal Cells
    Figure 11. Global Cell Viability Assays Market Share by Type in 2022 & 2028
    Figure 12. Global Cell Viability Assays Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Cell Viability Assays Market Share by Type (2017-2028)
    Figure 14. United States Cell Viability Assays Market Share by Type in 2022 & 2028
    Figure 15. United States Cell Viability Assays Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Cell Viability Assays Market Share by Type (2017-2028)
    Figure 17. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 18. Product Picture of Academic and Research Institutes
    Figure 19. Product Picture of Hospital and Diagnostic Laboratories
    Figure 20. Product Picture of Others
    Figure 21. Global Cell Viability Assays Market Share by Application in 2022 & 2028
    Figure 22. Global Cell Viability Assays Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Cell Viability Assays Market Share by Application (2017-2028)
    Figure 24. United States Cell Viability Assays Market Share by Application in 2022 & 2028
    Figure 25. United States Cell Viability Assays Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Cell Viability Assays Market Share by Application (2017-2028)
    Figure 27. North America Cell Viability Assays Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Cell Viability Assays Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Cell Viability Assays Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Cell Viability Assays Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Cell Viability Assays Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. UAE Cell Viability Assays Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 57. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 58. GE Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 59. Danaher Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 60. BD Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 61. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 62. Promega Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 63. Biotium Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 64. Abcam Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 65. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 66. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Merck
Bio-Rad
GE
Danaher
BD
PerkinElmer
Promega
Biotium
Abcam
Creative Bioarray
Biotek Instruments
Frequently Asked Questions
Cell Viability Assays report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell Viability Assays report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell Viability Assays report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Odontogenic Tumor

Odontogenic Tumor market is segmented by region (country), players, by Type and by Application. P ... Read More

Fertility Services

Fertility Services market is segmented by region (country), players, by Type and by Application.  ... Read More